Brief: Ascelia Pharma Q4 EBIT SEK -21.9 Million

Ascelia Pharma AB

07/02/2025 06:30

Feb 07 (Reuters) - Ascelia Pharma Q4 cash flow from operations SEK -18.8
million.
* Q4 EPS SEK -0.29